StoneX Group’s Akili Inc AKLI Stock Holding History

StoneX Group’s Portfolio AKLI Stock Details AKLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,064,432	Closed	-$518K	–	748
2023 Q4	$518K	Buy	+1,064,432	New	+$491K	0.05%	296

Other funds holding AKLI

SCG

Social Capital Group Menlo Park, California $5.16M AUM 66.85% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

TPC

Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Longitude (Cayman) Grand Cayman, Cayman Islands $314M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

StoneX Group's AKLI Position: Q1 2024 in Review

StoneX Group sold out of Akili Inc (AKLI) in Q1 2024, closing a stake of 1,064,432 shares — an estimated $518K sold.

StoneX Group first reported a position in AKLI in Q4 2023 and held it in 1 quarter. The position peaked at $518K in Q4 2023. 34 funds tracked by Wall St. Rank hold AKLI as of Q1 2024.

StoneX Group reported no remaining Akili Inc position as of Q1 2024 after selling out during the quarter.
StoneX Group sold 1,064,432 Akili Inc shares in Q1 2024, an estimated $518K.
StoneX Group first reported a position in Akili Inc in Q4 2023 and held it in 1 quarter.
StoneX Group's Akili Inc position peaked at $518K in Q4 2023.
34 funds tracked by Wall St. Rank held Akili Inc as of Q1 2024.

Based on StoneX Group's 13F filing for Q1 2024, filed 1 May 2024.